Acute Kidney Injury Treatment Market by Therapy Type and Distribution Channel - Global Industry Analysis & Forecast to 2027

Published On : December 2020 Pages : 157 Category: Pharma & Healthcare Report Code : HC1214012

Acute Kidney Injury Treatment Market By Therapy Type (Intermittent hemodialysis, Continuous renal replacement therapy, Sustained low-efficiency dialysis) and Distribution Channel (Hospitals Pharmacies, Retail Pharmacies, Online Pharmacies)- Global Industry Analysis & Forecast to 2027

Industry Outlook and Trend Analysis

The Acute Kidney Injury Treatment Markethas encountered significant development over the recent years and is anticipated to grow tremendously over the forecast period.Acute Kidney Injuryis the loss in kidney function, characterized increasing serum creatinine level without loss urine. These injuries cause due to building of waste products in the blood.Acute kidney injury is most common in patients admitted at hospital, intensive care units (ICU), among older adults.

Drivers and Restraints

Top-down and bottom-up approaches are used to validate the global Acute Kidney Injury Treatment Market and estimate the market size for company, regions segments, type segments and applications (end users). In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.

Regional Insights

The data for 2020 is an estimate, based on the history data and the integrated view of industry experts, manufacturers, distributors and end users etc.

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Russia
    • Italy
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • South Korea
    • India
    • Southeast Asia
    • Rest of Asia-Pacific
  • SouthAmerica
    • Brazil
    • Argentina
    • Columbia
    • Rest of South America
  • Middle East and Africa
    • Saudi Arabia
    • UAE
    • Egypt
    • Nigeria
    • South Africa
    • Turkey
    • Rest of MEA

Competitive Analysis                         

The major players in the market are profiled in detail in view of qualities, for example, company portfolio, business strategies, financial overview, recent developments, and share of the overall industry.

  • Novartis AG
  • Pfizer Inc.
  • Ipsen SA
  • Merck & Co., Inc.
  • Celegene Corp.
  • Conatus Pharmaceuticals Inc.
  • Valeant Pharmaceuticals International Inc.
  • Teva Pharmaceutical Industries Ltd.
  • Mylan Pharmaceuticals Inc.

Some of the key questions answered by the report are:

  • What was the market size in 2014 and forecast from 2020 to 2027?
  • What will be the industry market growth from 2016 to 2027?
  • What are the major drivers, restraints, opportunities, challenges, and industry trends and their impact on the market forecast?
  • What are the major segments leading the market growth and why?
  • Which are the leading players in the market and what are the major strategies adopted by them to sustain the market competition?

Market Classification

·         Acute Kidney Injury Treatment Market, ByTherapyType, Estimates and Forecast, 2016-2027 ($Million)

o    Intermittent hemodialysis

o    Continuous renal replacement therapy

o    Sustained low-efficiency dialysis

·         Acute Kidney Injury Treatment Market, ByDistribution Channel, Estimates and Forecast, 2016-2027 ($Million)

o    Hospitals Pharmacies

o    Retail Pharmacies

o    Online Pharmacies

·         Acute Kidney Injury Treatment Market, By Key Players, Estimates and Forecast, 2016-2027 ($Million)

o    Novartis AG

o    Pfizer Inc.

o    Ipsen SA

o    Merck & Co., Inc.

o    Celegene Corp.

o    Conatus Pharmaceuticals Inc.

o    Valeant Pharmaceuticals International Inc.

o    Teva Pharmaceutical Industries Ltd.

o    Mylan Pharmaceuticals Inc.

·         Acute Kidney Injury Treatment Market, By Region, Estimates and Forecast, 2016-2027 ($Million)

o    North America

§  North America Acute Kidney Injury Treatment Market, By Country

o    U.S. Acute Kidney Injury Treatment Market

o    Canada Acute Kidney Injury Treatment Market

o    Mexico Acute Kidney Injury Treatment Market

o    Europe

§  Europe Acute Kidney Injury Treatment Market, By Country

o    UK Acute Kidney Injury Treatment Market

o    Germany Acute Kidney Injury Treatment Market

o    France Acute Kidney Injury Treatment Market

o    Russia Acute Kidney Injury Treatment Market

o    Italy Acute Kidney Injury Treatment Market

o    Rest of Europe Acute Kidney Injury Treatment Market

o    Asia-Pacific

§  Asia-Pacific Acute Kidney Injury Treatment Market, By Country

o    China Acute Kidney Injury Treatment Market

o    Japan Acute Kidney Injury Treatment Market

o    South Korea Acute Kidney Injury Treatment Market

o    India Acute Kidney Injury Treatment Market

o    Southeast Asia Acute Kidney Injury Treatment Market

o    Rest of Asia-Pacific Acute Kidney Injury Treatment Market

o    South America

§  South America Acute Kidney Injury Treatment Market

o    Brazil Acute Kidney Injury Treatment Market

o    Argentina Acute Kidney Injury Treatment Market

o    Columbia Acute Kidney Injury Treatment Market

o    Rest of South America Acute Kidney Injury Treatment Market

o    Middle East and Africa

§  Middle East and Africa Acute Kidney Injury Treatment Market

o    Saudi Arabia Acute Kidney Injury Treatment Market

o    UAE Acute Kidney Injury Treatment Market

o    Egypt Acute Kidney Injury Treatment Market

o    Nigeria Acute Kidney Injury Treatment Market

o    South Africa Acute Kidney Injury Treatment Market

o    TurkeyAcute Kidney Injury Treatment Market

o    Rest of MEA Acute Kidney Injury Treatment Market 

Table of Contents:

1.       Introduction

1.1.     Report Description

2.       Executive Summary

2.1.     Key Highlights

3.       Market Overview

3.1.     Introduction

3.1.1.  Market Definition

3.1.2.  Market Segmentation

3.2.     Market Dynamics

3.2.1.  Drivers

3.2.2.  Restraints

3.2.3.  Opportunities

4.       Market Analysis by Regions

4.1.     North America (United States, Canada and Mexico)

4.1.1.  United States Market Status and Outlook (2016-2027)

4.1.2.  Canada Market Status and Outlook (2016-2027)

4.1.3.  Mexico Market Status and Outlook (2016-2027)

4.2.     Europe (Germany, France, UK, Russia, Italy and Rest of Europe)

4.2.1.  Germany Market Status and Outlook (2016-2027)

4.2.2.  France Market Status and Outlook (2016-2027)

4.2.3.  UK Market Status and Outlook (2016-2027)

4.2.4.  Russia Market Status and Outlook (2016-2027)

4.2.5.  Italy Market Status and Outlook (2016-2027)

4.2.6.  Rest of Europe Market Status and Outlook (2016-2027)

4.3.     Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Rest of Asia-Pacific)

4.3.1.  China Market Status and Outlook (2016-2027)

4.3.2.  Japan Market Status and Outlook (2016-2027)

4.3.3.  Korea Market Status and Outlook (2016-2027)

4.3.4.  India Market Status and Outlook (2016-2027)

4.3.5.  Southeast Asia Market Status and Outlook (2016-2027)

4.3.6.  Rest of Asia-Pacific Market Status and Outlook (2016-2027)

4.4.     South America (Brazil, Argentina, Columbia and Rest of South America)

4.4.1.  Brazil Market Status and Outlook (2016-2027)

4.4.2.  Argentina Market Status and Outlook (2016-2027)

4.4.3.  Columbia Market Status and Outlook (2016-2027)

4.4.4.  Rest of South America Market Status and Outlook (2016-2027)

4.5.     Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa and Rest of MEA)

4.5.1.  Saudi Arabia Market Status and Outlook (2016-2027)

4.5.2.  United Arab Emirates Market Status and Outlook (2016-2027)

4.5.3.  Egypt Market Status and Outlook (2016-2027)

4.5.4.  Nigeria Market Status and Outlook (2016-2027)

4.5.5.  South Africa Market Status and Outlook (2016-2027)

4.5.6.  Turkey Market Status and Outlook (2016-2027)

4.5.7.  Rest of Middle East and Africa Market Status and Outlook (2016-2027)

5.       Acute Kidney Injury Treatment  Market, By Therapy Type

5.1.     Introduction

5.2.     Global Acute Kidney Injury Treatment  Revenue and Market Share by Therapy Type (2016-2019)

5.2.1.  Global Acute Kidney Injury Treatment  Revenue and Revenue Share by Therapy Type (2016-2019)

5.3.     Intermittent hemodialysis

5.3.1.  Global Intermittent hemodialysis Revenue and Growth Rate (2016-2019)

5.4.     Continuous renal replacement therapy

5.4.1.  Global Continuous renal replacement therapy Revenue and Growth Rate (2016-2019)

5.5.     Sustained low-efficiency dialysis

5.5.1.  Global Sustained low-efficiency dialysis Revenue and Growth Rate (2016-2019)

6.       Acute Kidney Injury Treatment  Market, By Distribution Channel

6.1.     Introduction

6.2.     Global Acute Kidney Injury Treatment  Revenue and Market Share by Distribution Channel (2016-2019)

6.2.1.  Global Acute Kidney Injury Treatment  Revenue and Revenue Share by Distribution Channel (2016-2019)

6.3.     Hospitals Pharmacies

6.3.1.  Global Hospitals Pharmacies Revenue and Growth Rate (2016-2019)

6.4.     Retail Pharmacies

6.4.1.  Global Retail Pharmacies Revenue and Growth Rate (2016-2019)

6.5.     Online Pharmacies

6.5.1.  Global Online Pharmacies Revenue and Growth Rate (2016-2019)

7.       Acute Kidney Injury Treatment  Market, By Region

7.1.     Introduction

7.2.     Global Acute Kidney Injury Treatment  Revenue and Market Share by Regions

7.2.1.  Global Acute Kidney Injury Treatment  Revenue by Regions (2016-2019)

7.3.     North America Acute Kidney Injury Treatment  by Countries

7.3.1.  North America Acute Kidney Injury Treatment  Revenue and Growth Rate (2016-2019)

7.3.2.  North America Acute Kidney Injury Treatment  Revenue (Million USD) by Countries (2016-2019)

7.3.3.  United States

7.3.3.1.  United States Acute Kidney Injury Treatment  Revenue (Millions USD) and Growth Rate (2016-2019)

7.3.4.  Canada

7.3.4.1.  Canada Acute Kidney Injury Treatment  Revenue (Millions USD) and Growth Rate (2016-2019)

7.3.5.  Mexico

7.3.5.1.  Mexico Acute Kidney Injury Treatment  Revenue (Millions USD) and Growth Rate (2016-2019)

7.4.     Europe Acute Kidney Injury Treatment  by Countries

7.4.1.  Europe Acute Kidney Injury Treatment  Revenue and Growth Rate (2016-2019)

7.4.2.  Europe Acute Kidney Injury Treatment  Revenue (Million USD) by Countries (2016-2019)

7.4.3.  Germany

7.4.3.1.  Germany Acute Kidney Injury Treatment  Revenue (Millions USD) and Growth Rate (2016-2019)

7.4.4.  France

7.4.4.1.  France Acute Kidney Injury Treatment  Revenue (Millions USD) and Growth Rate (2016-2019)

7.4.5.  UK

7.4.5.1.  UK Acute Kidney Injury Treatment  Revenue (Millions USD) and Growth Rate (2016-2019)

7.4.6.  Russia

7.4.6.1.  Russia Acute Kidney Injury Treatment  Revenue (Millions USD) and Growth Rate (2016-2019)

7.4.7.  Italy

7.4.7.1.  Italy Acute Kidney Injury Treatment  Revenue (Millions USD) and Growth Rate (2016-2019)

7.4.8.  Rest of Europe

7.4.8.1.  Rest of Europe Acute Kidney Injury Treatment  Revenue (Millions USD) and Growth Rate (2016-2019)

7.5.     Asia-Pacific Acute Kidney Injury Treatment  by Countries

7.5.1.  Asia-Pacific Acute Kidney Injury Treatment  Revenue and Growth Rate (2016-2019)

7.5.2.  Asia-Pacific Acute Kidney Injury Treatment  Revenue (Million USD) by Countries (2016-2019)

7.5.3.  China

7.5.3.1.  China Acute Kidney Injury Treatment  Revenue (Millions USD) and Growth Rate (2016-2019)

7.5.4.  Japan

7.5.4.1.  Japan Acute Kidney Injury Treatment  Revenue (Millions USD) and Growth Rate (2016-2019)

7.5.5.  Korea

7.5.5.1.  Korea Acute Kidney Injury Treatment  Revenue (Millions USD) and Growth Rate (2016-2019)

7.5.6.  India

7.5.6.1.  India Acute Kidney Injury Treatment  Revenue (Millions USD) and Growth Rate (2016-2019)

7.5.7.  Southeast Asia

7.5.7.1.  Southeast Asia Acute Kidney Injury Treatment  Revenue (Millions USD) and Growth Rate (2016-2019)

7.5.8.  Rest of Asia-Pacific

7.5.8.1.  Rest of Asia-Pacific Acute Kidney Injury Treatment  Revenue (Millions USD) and Growth Rate (2016-2019)

7.6.     South America Acute Kidney Injury Treatment  by Countries

7.6.1.  South America Acute Kidney Injury Treatment  Revenue and Growth Rate (2016-2019)

7.6.2.  South America Acute Kidney Injury Treatment  Revenue (Million USD) by Countries (2016-2019)

7.6.3.  Brazil

7.6.3.1.  Brazil Acute Kidney Injury Treatment  Revenue (Millions USD) and Growth Rate (2016-2019)

7.6.4.  Argentina

7.6.4.1.  Argentina Acute Kidney Injury Treatment  Revenue (Millions USD) and Growth Rate (2016-2019)

7.6.5.  Columbia

7.6.5.1.  Columbia Acute Kidney Injury Treatment  Revenue (Millions USD) and Growth Rate (2016-2019)

7.6.6.  Rest of South America

7.6.6.1.  Rest of South America Acute Kidney Injury Treatment  Revenue (Millions USD) and Growth Rate (2016-2019)

7.7.     Middle East and Africa Acute Kidney Injury Treatment  by Countries

7.7.1.  Middle East and Africa Acute Kidney Injury Treatment  Revenue and Growth Rate (2016-2019)

7.7.2.  Middle East and Africa Acute Kidney Injury Treatment  Revenue (Million USD) by Countries (2016-2019)

7.7.3.  Saudi Arabia

7.7.3.1.  Saudi Arabia Acute Kidney Injury Treatment  Revenue (Millions USD) and Growth Rate (2016-2019)

7.7.4.  United Arab Emirates

7.7.4.1.  United Arab Emirates Acute Kidney Injury Treatment  Revenue (Millions USD) and Growth Rate (2016-2019)

7.7.5.  Egypt

7.7.5.1.  Egypt Acute Kidney Injury Treatment  Revenue (Millions USD) and Growth Rate (2016-2019)

7.7.6.  Nigeria

7.7.6.1.  Nigeria Acute Kidney Injury Treatment  Revenue (Millions USD) and Growth Rate (2016-2019)

7.7.7.  South Africa

7.7.7.1.  South Africa Acute Kidney Injury Treatment  Revenue (Millions USD) and Growth Rate (2016-2019)

7.7.8.  Turkey

7.7.8.1.  Turkey Acute Kidney Injury Treatment  Revenue (Millions USD) and Growth Rate (2016-2019)

7.7.9.  Rest of Middle East and Africa

7.7.9.1.  Rest of Middle East and Africa Acute Kidney Injury Treatment  Revenue (Millions USD) and Growth Rate (2016-2019)

8.       Company Profiles

8.1.     Novartis AG

8.1.1.  Business Overview

8.1.2.   Service Portfolio

8.1.3.  Strategic Developments

8.1.4.  Financial Overview

8.2.     Pfizer Inc.

8.2.1.  Business Overview

8.2.2.   Service Portfolio

8.2.3.  Strategic Developments

8.2.4.  Financial Overview

8.3.     Ipsen SA

8.3.1.  Business Overview

8.3.2.   Service Portfolio

8.3.3.  Strategic Developments

8.3.4.  Financial Overview

8.4.     Merck & Co., Inc.

8.4.1.  Business Overview

8.4.2.   Service Portfolio

8.4.3.  Strategic Developments

8.4.4.  Financial Overview

8.5.     Celegene Corp.

8.5.1.  Business Overview

8.5.2.   Service Portfolio

8.5.3.  Strategic Developments

8.5.4.  Financial Overview

8.6.     Conatus Pharmaceuticals Inc.

8.6.1.  Business Overview

8.6.2.   Service Portfolio

8.6.3.  Strategic Developments

8.6.4.  Financial Overview

8.7.     Valeant Pharmaceuticals International Inc.

8.7.1.  Business Overview

8.7.2.   Service Portfolio

8.7.3.  Strategic Developments

8.7.4.  Financial Overview

8.8.     Teva Pharmaceutical Industries Ltd.

8.8.1.  Business Overview

8.8.2.   Service Portfolio

8.8.3.  Strategic Developments

8.8.4.  Financial Overview

8.9.     Mylan Pharmaceuticals Inc.

8.9.1.  Business Overview

8.9.2.   Service Portfolio

8.9.3.  Strategic Developments

8.9.4.  Financial Overview

9.       Acute Kidney Injury Treatment  Market Forecast (2019-2027)

9.1.     Global Acute Kidney Injury Treatment  Revenue (Millions USD) and Growth Rate (2019-2027)

9.2.     Acute Kidney Injury Treatment  Market Forecast by Regions (2019-2027)

9.2.1.  North America Acute Kidney Injury Treatment  Market Forecast (2019-2027)

9.2.1.1.  United States Acute Kidney Injury Treatment  Market Forecast (2019-2027)

9.2.1.2.  Canada Acute Kidney Injury Treatment  Market Forecast (2019-2027)

9.2.1.3.  Mexico Acute Kidney Injury Treatment  Market Forecast (2019-2027)

9.2.2.  Europe Acute Kidney Injury Treatment  Market Forecast (2019-2027)

9.2.2.1.  Germany Acute Kidney Injury Treatment  Market Forecast (2019-2027)

9.2.2.2.  France Acute Kidney Injury Treatment  Market Forecast (2019-2027)

9.2.2.3.  UK Acute Kidney Injury Treatment  Market Forecast (2019-2027)

9.2.2.4.  Russia Acute Kidney Injury Treatment  Market Forecast (2019-2027)

9.2.2.5.  Italy Acute Kidney Injury Treatment  Market Forecast (2019-2027)

9.2.2.6.  Rest of Europe Acute Kidney Injury Treatment  Market Forecast (2019-2027)

9.2.3.  Asia-Pacific Acute Kidney Injury Treatment  Market Forecast (2019-2027)

9.2.3.1.  China Acute Kidney Injury Treatment  Market Forecast (2019-2027)

9.2.3.2.  Japan Acute Kidney Injury Treatment  Market Forecast (2019-2027)

9.2.3.3.  Korea Acute Kidney Injury Treatment  Market Forecast (2019-2027)

9.2.3.4.  India Acute Kidney Injury Treatment  Market Forecast (2019-2027)

9.2.3.5.  Southeast Asia Acute Kidney Injury Treatment  Market Forecast (2019-2027)

9.2.3.6.  Rest of Asia-Pacific Acute Kidney Injury Treatment  Market Forecast (2019-2027)

9.2.4.  South America Acute Kidney Injury Treatment  Market Forecast (2019-2027)

9.2.4.1.  Brazil Acute Kidney Injury Treatment  Market Forecast (2019-2027)

9.2.4.2.  Argentina Acute Kidney Injury Treatment  Market Forecast (2019-2027)

9.2.4.3.  Columbia Acute Kidney Injury Treatment  Market Forecast (2019-2027)

9.2.4.4.  Rest of South America Acute Kidney Injury Treatment  Market Forecast (2019-2027)

9.2.5.  Middle East and Africa Acute Kidney Injury Treatment  Market Forecast (2019-2027)

9.2.5.1.  Saudi Arabia Acute Kidney Injury Treatment  Market Forecast (2019-2027)

9.2.5.2.  United Arab Emirates Acute Kidney Injury Treatment  Market Forecast (2019-2027)

9.2.5.3.  Egypt Acute Kidney Injury Treatment  Market Forecast (2019-2027)

9.2.5.4.  Nigeria Acute Kidney Injury Treatment  Market Forecast (2019-2027)

9.2.5.5.  South Africa Acute Kidney Injury Treatment  Market Forecast (2019-2027)

9.2.5.6.  Turkey Acute Kidney Injury Treatment  Market Forecast (2019-2027)

9.2.5.7.  Rest of Middle East and Africa Acute Kidney Injury Treatment  Market Forecast (2019-2027)

9.3.     Acute Kidney Injury Treatment  Market Forecast by Therapy Type (2019-2027)

9.3.1.  Acute Kidney Injury Treatment  Forecast by Therapy Type (2019-2027)

9.3.2.  Acute Kidney Injury Treatment  Market Share Forecast by Therapy Type (2019-2027)

9.4.     Acute Kidney Injury Treatment  Market Forecast by Distribution Channel (2019-2027)

9.4.1.  Acute Kidney Injury Treatment  Forecast by Distribution Channel (2019-2027)

9.4.2.  Acute Kidney Injury Treatment  Market Share Forecast by Distribution Channel (2019-2027)


List of Tables

List of Tables and Figures:

Figure United States Acute Kidney Injury Treatment Revenue (Million USD) and Growth Rate (2016-2027)
Figure Canada Acute Kidney Injury Treatment Revenue (Million USD) and Growth Rate (2016-2027)
Figure Mexico Acute Kidney Injury Treatment Revenue (Million USD) and Growth Rate (2016-2027)
Figure Germany Acute Kidney Injury Treatment Revenue (Million USD) and Growth Rate (2016-2027)
Figure France Acute Kidney Injury Treatment Revenue (Million USD) and Growth Rate (2016-2027)
Figure UK Acute Kidney Injury Treatment Revenue (Million USD) and Growth Rate (2016-2027)
Figure Russia Acute Kidney Injury Treatment Revenue (Million USD) and Growth Rate (2016-2027)
Figure Italy Acute Kidney Injury Treatment Revenue (Million USD) and Growth Rate (2016-2027)
Figure Rest of Europe Acute Kidney Injury Treatment Revenue (Million USD) and Growth Rate (2016-2027)
Figure China Acute Kidney Injury Treatment Revenue (Million USD) and Growth Rate (2016-2027)
Figure Japan Acute Kidney Injury Treatment Revenue (Million USD) and Growth Rate (2016-2027)
Figure Korea Acute Kidney Injury Treatment Revenue (Million USD) and Growth Rate (2016-2027)
Figure India Acute Kidney Injury Treatment Revenue (Million USD) and Growth Rate (2016-2027)
Figure Southeast Asia Acute Kidney Injury Treatment Revenue (Million USD) and Growth Rate (2016-2027)
Figure Rest of Asia-Pacific Acute Kidney Injury Treatment Revenue (Million USD) and Growth Rate (2016-2027)
Figure Brazil Acute Kidney Injury Treatment Revenue (Million USD) and Growth Rate (2016-2027)
Figure Argentina Acute Kidney Injury Treatment Revenue (Million USD) and Growth Rate (2016-2027)
Figure Columbia Acute Kidney Injury Treatment Revenue (Million USD) and Growth Rate (2016-2027)
Figure Rest of South America Acute Kidney Injury Treatment Revenue (Million USD) and Growth Rate (2016-2027)
Figure Saudi Arabia Acute Kidney Injury Treatment Revenue (Million USD) and Growth Rate (2016-2027)
Figure United Arab Emirates Acute Kidney Injury Treatment Revenue (Million USD) and Growth Rate (2016-2027)
Figure Egypt Acute Kidney Injury Treatment Revenue (Million USD) and Growth Rate (2016-2027)
Figure Nigeria Acute Kidney Injury Treatment Revenue (Million USD) and Growth Rate (2016-2027)
Figure South Africa Acute Kidney Injury Treatment Revenue (Million USD) and Growth Rate (2016-2027)
Figure Turkey Acute Kidney Injury Treatment Revenue (Million USD) and Growth Rate (2016-2027)
Figure Rest of Middle East and Africa Acute Kidney Injury Treatment Revenue (Million USD) and Growth Rate (2016-2027)
Table Global Acute Kidney Injury Treatment Revenue and Revenue Share by Therapy Type (2016-2019)
Figure Global Intermittent hemodialysis Revenue and Growth Rate (2016-2019)
Figure Global Continuous renal replacement therapy Revenue and Growth Rate (2016-2019)
Figure Global Sustained low-efficiency dialysis Revenue and Growth Rate (2016-2019)
Table Global Acute Kidney Injury Treatment Revenue and Revenue Share by Distribution Channel (2016-2019)
Figure Global Hospitals Pharmacies Revenue and Growth Rate (2016-2019)
Figure Global Retail Pharmacies Revenue and Growth Rate (2016-2019)
Figure Global Online Pharmacies Revenue and Growth Rate (2016-2019)
Table Global Acute Kidney Injury Treatment Revenue by Regions (2016-2019)
Figure North America Acute Kidney Injury Treatment Growth Rate (2016-2019)
Figure North America Acute Kidney Injury Treatment Revenue and Growth Rate (2016-2019)
Figure North America Acute Kidney Injury Treatment by Countries (2016-2019)
Figure North America Acute Kidney Injury Treatment Revenue (Million USD) by Countries (2016-2019)
Figure United States Acute Kidney Injury Treatment Growth Rate (2016-2019)
Figure United States Acute Kidney Injury Treatment Revenue (Millions USD) and Growth Rate (2016-2019)
Figure Canada Acute Kidney Injury Treatment Growth Rate (2016-2019)
Figure Canada Acute Kidney Injury Treatment Revenue (Millions USD) and Growth Rate (2016-2019)
Figure Mexico Acute Kidney Injury Treatment Growth Rate (2016-2019)
Figure Mexico Acute Kidney Injury Treatment Revenue (Millions USD) and Growth Rate (2016-2019)
Figure Europe Acute Kidney Injury Treatment Growth Rate (2016-2019)
Figure Europe Acute Kidney Injury Treatment Revenue and Growth Rate (2016-2019)
Figure Europe Acute Kidney Injury Treatment by Countries (2016-2019)
Figure Europe Acute Kidney Injury Treatment Revenue (Million USD) by Countries (2016-2019)
Figure Germany Acute Kidney Injury Treatment Growth Rate (2016-2019)
Figure Germany Acute Kidney Injury Treatment Revenue (Millions USD) and Growth Rate (2016-2019)
Figure France Acute Kidney Injury Treatment Growth Rate (2016-2019)
Figure France Acute Kidney Injury Treatment Revenue (Millions USD) and Growth Rate (2016-2019)
Figure UK Acute Kidney Injury Treatment Growth Rate (2016-2019)
Figure UK Acute Kidney Injury Treatment Revenue (Millions USD) and Growth Rate (2016-2019)
Figure Russia Acute Kidney Injury Treatment Growth Rate (2016-2019)
Figure Russia Acute Kidney Injury Treatment Revenue (Millions USD) and Growth Rate (2016-2019)
Figure Italy Acute Kidney Injury Treatment Growth Rate (2016-2019)
Figure Italy Acute Kidney Injury Treatment Revenue (Millions USD) and Growth Rate (2016-2019)
Figure Rest of Europe Acute Kidney Injury Treatment Growth Rate (2016-2019)
Figure Rest of Europe Acute Kidney Injury Treatment Revenue (Millions USD) and Growth Rate (2016-2019)
Figure Asia-Pacific Acute Kidney Injury Treatment Growth Rate (2016-2019)
Figure Asia-Pacific Acute Kidney Injury Treatment Revenue and Growth Rate (2016-2019)
Figure Asia-Pacific Acute Kidney Injury Treatment by Countries (2016-2019)
Figure Asia-Pacific Acute Kidney Injury Treatment Revenue (Million USD) by Countries (2016-2019)
Figure China Acute Kidney Injury Treatment Growth Rate (2016-2019)
Figure China Acute Kidney Injury Treatment Revenue (Millions USD) and Growth Rate (2016-2019)
Figure Japan Acute Kidney Injury Treatment Growth Rate (2016-2019)
Figure Japan Acute Kidney Injury Treatment Revenue (Millions USD) and Growth Rate (2016-2019)
Figure Korea Acute Kidney Injury Treatment Growth Rate (2016-2019)
Figure Korea Acute Kidney Injury Treatment Revenue (Millions USD) and Growth Rate (2016-2019)
Figure India Acute Kidney Injury Treatment Growth Rate (2016-2019)
Figure India Acute Kidney Injury Treatment Revenue (Millions USD) and Growth Rate (2016-2019)
Figure Southeast Asia Acute Kidney Injury Treatment Growth Rate (2016-2019)
Figure Southeast Asia Acute Kidney Injury Treatment Revenue (Millions USD) and Growth Rate (2016-2019)
Figure Rest of Asia-Pacific Acute Kidney Injury Treatment Growth Rate (2016-2019)
Figure Rest of Asia-Pacific Acute Kidney Injury Treatment Revenue (Millions USD) and Growth Rate (2016-2019)
Figure South America Acute Kidney Injury Treatment Growth Rate (2016-2019)
Figure South America Acute Kidney Injury Treatment Revenue and Growth Rate (2016-2019)
Figure South America Acute Kidney Injury Treatment by Countries (2016-2019)
Figure South America Acute Kidney Injury Treatment Revenue (Million USD) by Countries (2016-2019)
Figure Brazil Acute Kidney Injury Treatment Growth Rate (2016-2019)
Figure Brazil Acute Kidney Injury Treatment Revenue (Millions USD) and Growth Rate (2016-2019)
Figure Argentina Acute Kidney Injury Treatment Growth Rate (2016-2019)
Figure Argentina Acute Kidney Injury Treatment Revenue (Millions USD) and Growth Rate (2016-2019)
Figure Columbia Acute Kidney Injury Treatment Growth Rate (2016-2019)
Figure Columbia Acute Kidney Injury Treatment Revenue (Millions USD) and Growth Rate (2016-2019)
Figure Rest of South America Acute Kidney Injury Treatment Growth Rate (2016-2019)
Figure Rest of South America Acute Kidney Injury Treatment Revenue (Millions USD) and Growth Rate (2016-2019)
Figure Middle East and Africa Acute Kidney Injury Treatment Growth Rate (2016-2019)
Figure Middle East and Africa Acute Kidney Injury Treatment Revenue and Growth Rate (2016-2019)
Figure Middle East and Africa Acute Kidney Injury Treatment by Countries (2016-2019)
Figure Middle East and Africa Acute Kidney Injury Treatment Revenue (Million USD) by Countries (2016-2019)
Figure Saudi Arabia Acute Kidney Injury Treatment Growth Rate (2016-2019)
Figure Saudi Arabia Acute Kidney Injury Treatment Revenue (Millions USD) and Growth Rate (2016-2019)
Figure United Arab Emirates Acute Kidney Injury Treatment Growth Rate (2016-2019)
Figure United Arab Emirates Acute Kidney Injury Treatment Revenue (Millions USD) and Growth Rate (2016-2019)
Figure Egypt Acute Kidney Injury Treatment Growth Rate (2016-2019)
Figure Egypt Acute Kidney Injury Treatment Revenue (Millions USD) and Growth Rate (2016-2019)
Figure Nigeria Acute Kidney Injury Treatment Growth Rate (2016-2019)
Figure Nigeria Acute Kidney Injury Treatment Revenue (Millions USD) and Growth Rate (2016-2019)
Figure South Africa Acute Kidney Injury Treatment Growth Rate (2016-2019)
Figure South Africa Acute Kidney Injury Treatment Revenue (Millions USD) and Growth Rate (2016-2019)
Figure Turkey Acute Kidney Injury Treatment Growth Rate (2016-2019)
Figure Turkey Acute Kidney Injury Treatment Revenue (Millions USD) and Growth Rate (2016-2019)
Figure Rest of Middle East and Africa Acute Kidney Injury Treatment Growth Rate (2016-2019)
Figure Rest of Middle East and Africa Acute Kidney Injury Treatment Revenue (Millions USD) and Growth Rate (2016-2019)
Table Novartis AG Acute Kidney Injury Treatment Financial Overview
Table Pfizer Inc. Acute Kidney Injury Treatment Financial Overview
Table Ipsen SA Acute Kidney Injury Treatment Financial Overview
Table Merck & Co., Inc. Acute Kidney Injury Treatment Financial Overview
Table Celegene Corp. Acute Kidney Injury Treatment Financial Overview
Table Conatus Pharmaceuticals Inc. Acute Kidney Injury Treatment Financial Overview
Table Valeant Pharmaceuticals International Inc. Acute Kidney Injury Treatment Financial Overview
Table Teva Pharmaceutical Industries Ltd. Acute Kidney Injury Treatment Financial Overview
Table Mylan Pharmaceuticals Inc. Acute Kidney Injury Treatment Financial Overview
Figure Global Acute Kidney Injury Treatment Revenue (Millions USD) and Growth Rate (2019-2027)
Table Acute Kidney Injury Treatment Market Forecast by Regions (2019-2027)
Figure North America Acute Kidney Injury Treatment Market Forecast (2019-2027)
Figure United States Acute Kidney Injury Treatment Market Forecast (2019-2027)
Figure Canada Acute Kidney Injury Treatment Market Forecast (2019-2027)
Figure Mexico Acute Kidney Injury Treatment Market Forecast (2019-2027)
Figure Europe Acute Kidney Injury Treatment Market Forecast (2019-2027)
Figure Germany Acute Kidney Injury Treatment Market Forecast (2019-2027)
Figure France Acute Kidney Injury Treatment Market Forecast (2019-2027)
Figure UK Acute Kidney Injury Treatment Market Forecast (2019-2027)
Figure Russia Acute Kidney Injury Treatment Market Forecast (2019-2027)
Figure Italy Acute Kidney Injury Treatment Market Forecast (2019-2027)
Figure Rest of Europe Acute Kidney Injury Treatment Market Forecast (2019-2027)
Figure Asia-Pacific Acute Kidney Injury Treatment Market Forecast (2019-2027)
Figure China Acute Kidney Injury Treatment Market Forecast (2019-2027)
Figure Japan Acute Kidney Injury Treatment Market Forecast (2019-2027)
Figure Korea Acute Kidney Injury Treatment Market Forecast (2019-2027)
Figure India Acute Kidney Injury Treatment Market Forecast (2019-2027)
Figure Southeast Asia Acute Kidney Injury Treatment Market Forecast (2019-2027)
Figure Rest of Asia-Pacific Acute Kidney Injury Treatment Market Forecast (2019-2027)
Figure South America Acute Kidney Injury Treatment Market Forecast (2019-2027)
Figure Brazil Acute Kidney Injury Treatment Market Forecast (2019-2027)
Figure Argentina Acute Kidney Injury Treatment Market Forecast (2019-2027)
Figure Columbia Acute Kidney Injury Treatment Market Forecast (2019-2027)
Figure Rest of South America Acute Kidney Injury Treatment Market Forecast (2019-2027)
Figure Middle East and Africa Acute Kidney Injury Treatment Market Forecast (2019-2027)
Figure Saudi Arabia Acute Kidney Injury Treatment Market Forecast (2019-2027)
Figure United Arab Emirates Acute Kidney Injury Treatment Market Forecast (2019-2027)
Figure Egypt Acute Kidney Injury Treatment Market Forecast (2019-2027)
Figure Nigeria Acute Kidney Injury Treatment Market Forecast (2019-2027)
Figure South Africa Acute Kidney Injury Treatment Market Forecast (2019-2027)
Figure Turkey Acute Kidney Injury Treatment Market Forecast (2019-2027)
Figure Rest of Middle East and Africa Acute Kidney Injury Treatment Market Forecast (2019-2027)
Figure Global Acute Kidney Injury Treatment Forecast by Therapy Type (2019-2027)
Figure Global Acute Kidney Injury Treatment Market Share Forecast by Therapy Type (2019-2027)
Figure Global Acute Kidney Injury Treatment Forecast by Therapy Type (2019-2027)
Figure Global Acute Kidney Injury Treatment Forecast by Distribution Channel (2019-2027)
Figure Global Acute Kidney Injury Treatment Market Share Forecast by Distribution Channel (2019-2027)
Figure Global Acute Kidney Injury Treatment Forecast by Distribution Channel (2019-2027)

Please Note: Data related to the Companies are subject to Availability.


Research Methodology

We use both primary as well as secondary research for our market surveys, estimates and for developing forecast. Our research process commence by analyzing the problem which enable us to design the scope for our research study. Our research process is uniquely designed with enough flexibility to adjust according to changing nature of products and markets, while retaining core element to ensure reliability and accuracy in research findings. We understand both macro and micro-economic factors to evaluate and forecast different market segments.

Data Mining

Data is extensively collected through various secondary sources such as annual reports, investor presentations, SEC filings, and other corporate publications. We also refer trade magazines, technical journals, paid databases such as Factiva and Bloomberg, industry trade journals, scientific journals, and social media data to understand market dynamics and industry trends. Further, we also conduct primary research to understand market drivers, restraints, opportunities, challenges, and competitive scenario to build our analysis.

Data Collection Matrix

Data Collection Matrix

Supply Side

Demand Side

Primary Data Sources

  • Manufacturers
  • Distributors & Wholesalers
  • GPOs
  • Physicians/Specialist
  • Healthcare Providers
  • Consumers

Secondary Data Sources

  • Annual Reports/SEC Filings/ Investor Presentations/ Press Releases
  • Government/Associations Publications
  • Case Studies
  • Reference Customers

 

Market Modeling and Forecasting

We use epidemiology and capital equipment-based models to forecast market size of different segments at country and regional level.

  • Epidemiology-based Forecasting Model: This method uses epidemiology data gathered through various publications and from physicians to estimate population of patients, flow of treatment of individual disease and therapies. The data collected through this method includes statics on incidence of disease, population suffering from disease, and treatment population. This method is used to understand:
  • Number of patients for particular device or medical procedure and
  • Repeated use of particular device depending on health and condition of patient
  • Capital-based Forecasting Model: This method of forecasting is based on number of replacements, installed-based and new sales of capital equipment used in various healthcare and diagnostic centers. These three parameters are calculated and forecast is developed. Installation base is calculated as average number of units per facility; while sales for particular year is calculated from number of new and replace units. Secondary data is collected through various supply chain intermediaries and opinion leaders to arrive at installation and sales rate. These techniques help our analysts in validating market and developed market estimates and forecast.

We do forecast on basis of several parameters such as market drivers, market opportunities, industry trends government regulations, raw materials supply and trade dynamics to ensure relevance of forecast with market scenario. With increasing need to granulized information, we used bottom-up methodology for forecasting where we evaluate each regional segment differently and combined all forecast to develop final market forecast.

Data Validation

We believe primary research is a very important tool in analyzing and forecasting different markets. In order to make sure accuracy of our findings, our team conducts primary interviews at every stage of research to gain deep insights into current business environment and future trends and key developments in market. This includes use of various methods such as telephonic interviews, focus groups, face to face interviews and questionnaires to validate our research from all aspects. We validate our data through primary research from key industry leaders such as CEO, product managers, marketing managers, suppliers, distributors, and consumers are frequently interviewed. These interviews provide valuable insights which help us to have better market understanding besides validating our estimates and forecast.

Data Triangulation

data triangulation

Industry Analysis

Qualitative Data

Quantitative Data (2017-2025)

  • Market Dynamics (Drivers, Restraints, and Challenges)
  • Industry Trend Analysis
  • Market Opportunities
  • Government Policies and Regulations, Patent Analysis, and Reimbursement Policies
  • Porter’s Five Forces and PESTLE Analysis
  • Key Developments and Competitive Landscape
  • Market Assessment and Forecast
  • Market Assessment and Forecast, By Product
  • Market Assessment and Forecast, By Technology
  • Market Assessment and Forecast, By Application
  • Market Assessment and Forecast, By End User
  • Market Assessment and Forecast, By Region/Country

License Type

For Any Assistance

*
*
*
*
*